All News
EULAR 2022 – Day 3 Report
By now, those of us attending the meeting know how to find a free coffee or sprite, have found comfortable meeting nooks and know our way around! PAnd congrats to you virtual Rheums for mastering the multi-screen, multitask simultaneous consumption posters, tweets and oral abstract presentations.
Read Article
#OP0286 #EULAR2022 With no licensed therapy, we need a better and responsive outcome measure. Using data-driven method, SJÖGREN’S TOOL FOR ASSESSING RESPONSE (STAR) has been developed. This will be evaluated in NECESSITY RCTs across Europe @RheumNow https://t.co/U5Aj6bwWBy
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
So maybe, when it comes to delivering healthcare and telemedicine, we need to think about quality and efficiency? #EULAR2022 @RheumNow https://t.co/JMbQ1ZUB0o
David Liew drdavidliew ( View Tweet)
and, Robert Landewe argues, telemedicine is merely exchanging parcels of information.
Life visits deliver the chance for empathy #EULAR2022 @RheumNow https://t.co/2CKTJHfF7A
David Liew drdavidliew ( View Tweet)
Quality patient communication is actually critical to outcome #EULAR2022 @RheumNow https://t.co/37Z7hwrWmX
David Liew drdavidliew ( View Tweet)
What's the argument against that?
Fundamentally, empathy. The patient experience isn't just a product of miracle drugs - over time it's a multitude of factors that are what leads to happy patients
#EULAR2022 @RheumNow https://t.co/8GwhdT8cit
David Liew drdavidliew ( View Tweet)
and if we don't act, we leave it to the wild, wild west of the private market:
- designed for profit (not necessarily bad)
- but often at the cost of robust dedication to patient outcomes (always bad)
#EULAR2022 @RheumNow https://t.co/zfJWTZ3I1G
David Liew drdavidliew ( View Tweet)
In fact, in some select situations we can get by very well without seeing our patient at all?
#EULAR2022 @RheumNow https://t.co/4qcaj2KR9B
David Liew drdavidliew ( View Tweet)
So maybe telemedicine can bring us the efficiency that we badly need. In rheumatology, we're drowning in demand - is telemedicine part of the solution?
#EULAR2022 @RheumNow https://t.co/kHBIYRIvBA
David Liew drdavidliew ( View Tweet)
#EULAR2022 Debate happening now:
📺⚕️Telemedicine: Salvation or necessary evil?
@RheumNow
Eric Dein ericdeinmd ( View Tweet)
#EULAR2022
Rebuttal!
💻⚕️
Telemedicine improves patient-doctor relationship
Supplements F2F visits, making them more efficient
Patients are communicating, texting all the time
Can AI help improve early pt communication?
@ChristianDejaco
@RheumNow
Eric Dein ericdeinmd ( View Tweet)
Hilarious debate #EULAR2022 between Christian Dejaco and Robert Landewe on whether telemedicine is the future of rheumatology. In amongst the trash talking, here are some highlights @RheumNow
David Liew drdavidliew ( View Tweet)
#EULAR2022 Telemedicine: PROs
💻Triage, reduce wait time, direct other specialty referral
💻High agreement w F2F evaluation (79-97%)
💻Saves resources, react quickly to minor flare
💻Better adherence
@RheumNow
Eric Dein ericdeinmd ( View Tweet)
📲The great debate on Telemedicine 💻
R. Landewe warns us against "check box medicine" and its consequences on AxSpA overdiagnosis.
@RheumNow #EULAR2022 https://t.co/Xwg0aAdHwE
Aurelie Najm AurelieRheumo ( View Tweet)
#EULAR2022 @ChristianDejaco: Do we need see our patient at all?
Provocative statement asking if some disease states can be evaluated, diagnosed, educated and monitored digitally.
"It's already out there!" "Should we leave it to the market" or should rheum take a lead?
@RheumNow https://t.co/iMrlKZgtbg
Eric Dein ericdeinmd ( View Tweet)
Casado et al. Efficacy of US guided needle fragmentation or lavage for calcific tendonitis refractory subacromial injection. Mean VAS decreased from 7.6±1.5 to 4.5±3.8 at month 4, 82.9% radiologic improvement. No control group! @RheumNow #EULAR2022 OP0289 https://t.co/KarkB7XL8u
Links:
Richard Conway RichardPAConway ( View Tweet)
#EULAR2022 POS0276
Xray & US for CPPD:
US: sensitivity in all sites
Xray: highly specific, low sensitivity
Combo: Best for patients with Negative Xray or Inconclusive US (only one positive site)
@Rheumnow @MymaAlbaydaMD @USSONAR_Rh
Eric Dein ericdeinmd ( View Tweet)
PMR/GCA patients: should you be worried about how well your COVID vaccine worked?
Actually, post-two vaccines, pretty good Ab (&cellular) response, esp if not on MTX/PNL>10
Glad to see our PMR/GCA pts protected
@VasculitisUMCG @SleenYannick @ElisabethBrouw3 #EULAR2022 @RheumNow https://t.co/9vy0W4ojOF
David Liew drdavidliew ( View Tweet)
There's nothing like a good physical examination
Temporal artery exam & ultrasound vs temporal artery biopsy
n=97 consecutive ?GCA pts from Carlo Salvarini's group
Very decent PPV
Those TA exam findings can be hard to find, but they're gold dust.
POS0820 #EULAR2022 @RheumNow https://t.co/X9TzIqQBaB
David Liew drdavidliew ( View Tweet)
The third SARS-CoV-2 vaccine in IMID (RA, SpA, PsA, UC, CD) patients on immunosuppression improves the serologic response follow the first two vaccine doses and allowed them to close the gap compared to the two-dose vaccinated controls #EULAR2022 @RheumNow OP0192 Jyssum et al
Dr. Antoni Chan synovialjoints ( View Tweet)
